Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM): A Phase I Study
Latest Information Update: 13 Mar 2022
At a glance
- Drugs Sorafenib (Primary) ; Dexamethasone; Proton pump inhibitors
- Indications Adenocarcinoma; Advanced breast cancer; Brain metastases
- Focus Adverse reactions
- 04 Mar 2022 Status changed from active, no longer recruiting to completed.
- 26 Oct 2021 Planned primary completion date changed from 1 Nov 2021 to 1 Nov 2023.
- 23 Oct 2021 Planned End Date changed from 1 Nov 2021 to 1 Nov 2023.